Endocrine Abstracts

Background of Study: Some medications for the treatment of type 2 diabetes mellitus fail to achieve a continuous favorable glucose control in the long run during clinical use. Therefore we examined the durability of dipeptidyl peptidase-4 (DPP-4) inhibitor, sitagliptin which is relatively new to Japanese type 2 diabetic patients in clinical settings.Objectives and Methods: 117 subjects (M/F=65/52, Age: 66±10 y.o., duration of diabetes 12±8 y. b...